American Medical Association (AMA)

The American Medical Association (AMA) is the largest professional association and lobbying group of physicians and medical students. The AMA mission is to promote the art and science of medicine and the betterment of public health. The association represents physicians with a unified voice in courts and legislative bodies across the nation, removing obstacles that interfere with patient care, leading efforts to prevent chronic disease and confront public health crises, and driving the future of medicine to tackle the biggest challenges in healthcare.

RSS icon

Medical staff must have a say in what AI is adopted for patient care, says AMA

The American Medical Association adopted a policy calling for medical staff to be involved in decisions about adopting AI that may impact patient care.

The ASNC team at the 2024 AMA meeting, Georgia Lawrence, JD, ASNC director of regulatory affairs; Suman Tandon, MD, FASNC, delegate to the AMA HOD and cardiac imager at NYU Langone; and Kathy Flood, ASNC CEO. #AMA #AMA24 #AMA2024 #AMAHOD #ASNC

ASNC supports AMA effort to limit use of AI in prior authorization decisions

The American Society of Nuclear Cardiology (ASNC) supports an AMA policy that condemns the use AI to make prior authorization decisions rather than a doctor or clinician.

AMA wants insurers to be accountable when prior authorization harms patients

The American Medical Association (AMA) House of Delegates this week approved two policies aimed at increasing insurer accountability and transparency amid an explosion of prior authorization requirements.

The American Medical Association (AMA) House of Delegates today elected Bobby Mukkamala, MD, an otolaryngologist from Flint, Michigan, as president-elect of the AMA for the 2025-2026 term. Mukkamala will be inaugurated as AMA president in June 2025. Photo courtesy of the AMA

AMA elects new president heavily involved in Flint water contamination response

The American Medical Association (AMA) House of Delegates elected a new president and numerous other positions.

Drawing inspiration from the World War II “Why We Fight” campaign that rallied support for the U.S. war effort, American Medical Association (AMA) President Jesse M. Ehrenfeld, MD, MPH, drew comparisons with the uphill battles physicians are facing today with dwindling reimbursements, physicians shortages, burnout and administrative fights against prior authorization burdens and attempts to preserve access to telehealth. #AMA #AMAHOD24 #AMAHOD2024 #HOD #HOD24 #HOD2024

AMA president calls for physicians to take war-time footing in fight over reimbursement, care quality

Drawing inspiration from the World War II “Why We Fight” campaign that rallied support for the U.S. war effort, AMA President Jesse  Ehrenfeld, MD, spoke on the uphill battles physicians are facing today.

doctor in handcuffs after being arrested

AMA says Change Healthcare breach is crippling independent practices

A survey of physicians by the American Medical Association reveals that many practices are still losing revenue and struggling to make payroll as a result of the Change Healthcare hack.

doctor's open hand waiting for a payment

‘Concerning’ data connect industry payments to cardiologists with medical device use

U.S. physicians often receive payments from medical device manufacturers and pharmaceutical companies. New research in JAMA found a connection between receiving such payments and using specific devices—should the industry be concerned? 

Thumbnail

Falls, infections much more likely among Medicare patients treated at private equity-owned hospitals

Private equity is becoming more and more influential in many healthcare specialties, including cardiology. This has prompted increased speculation about the impact such investments may have on patient outcomes.

Displaying 9 - 16 of 67

Around the web

Cardiovascular Business
Philips to sell its emergency care business to private equity firm

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

AI in Healthcare
Nat’l Academy of Medicine sets ‘priorities for action’ as healthcare mulls next moves with AI

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

Cardiovascular Business
Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%.